MedPath

The effect of clodronate on the incidence of hip fracture and consequences for health and costs

Completed
Conditions
Orthopaedics, rheumatology
Musculoskeletal Diseases
Hip fracture
Registration Number
ISRCTN39259790
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
5700
Inclusion Criteria

Women aged 75 years or older willing to participate

Exclusion Criteria

Drugs and diseases likely to impair the efficacy of intervention or the interpretation of results

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fragility fractures, particularly hip fracture
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath